Frieman; Bryan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Frieman; Bryan.The latest application filed is for "modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators".

Company Profile

5.8.12

Frieman; Bryan - La Jolla CA
Frieman; Bryan - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators App 20220106331 - Clemens; Jeremy J. ; et al.	2022-04-07
Methods Of Treatment For Cystic Fibrosis App 20220047564 - ALTSHULER; David M. ; et al.	2022-02-17
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators Grant 11,066,417 - Clemens , et al. July 20, 2	2021-07-20
Process Of Making Cftr Modulators App 20210047345 - Angell; Paul ; et al.	2021-02-18
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator App 20210047350 - Anderson; Corey Don ; et al.	2021-02-18
Crystalline Forms Of Cftr Modulators App 20210047323 - Shi; Yi ; et al.	2021-02-18
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Proces App 20190248809 - Clemens; Jeremy J. ; et al.	2019-08-15
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists Grant 9,199,993 - Saito , et al. December 1, 2	2015-12-01
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide Compounds As Mu Opioid Receptor Antagonists App 20150051243 - Saito; Daisuke Roland ; et al.	2015-02-19
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists Grant 8,802,698 - Saito , et al. August 12, 2	2014-08-12
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide Compounds As Mu Opioid Receptor Antagonists App 20140080855 - Saito; Daisuke Roland ; et al.	2014-03-20
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists Grant 8,481,563 - Saito , et al. July 9, 2	2013-07-09
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide Compounds As Mu Opioid Receptor Antagonists App 20110118306 - Saito; Daisuke Roland ; et al.	2011-05-19
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists Grant 7,902,220 - Saito , et al. March 8, 2	2011-03-08
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists App 20090062333 - Saito; Daisuke Roland ; et al.	2009-03-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.